Rexahn Pharmaceuticals to Present at the 2nd Annual Sachs Cancer Bio Partnering & Investment Forum in New York Mar 17, 2014
Rexahn Announces Initial Results from Phase I Trial of SupinoxinTM (RX-5902) for Solid Cancer Tumors Mar 11, 2014
Rexahn Initiates Phase IIa Clinical Trial of Archexin® in Patients with Metastatic Renal Cell Carcinoma Jan 14, 2014
Rexahn Receives Method Patent for Treatment of Solid Tumor Cancers for Supinoxin TMÂ (RX-5902) Dec 11, 2013